Arigami T, Matsushita D, Okubo K, Shimonosono M, et al. Clinical Significance of Eligibility Criteria Determined by the SPIRITS Trial in Patients with Advanced Gastric Cancer. Oncology 2022 Oct 5. pii: 000527114. doi: 10.1159/000527114.
PMID: 36198262